Search results for: d842V

/Search: d842V
29 06, 2018

New Technology Developed Which Can Predict GIST Patient’s Response to Drugs with Amazing Accuracy

By |2019-07-03T10:48:28-04:00June 29th, 2018|GIST Education, Mutational Testing, News, Newsletter|

Researchers have developed a test that can accurately identify over 20% of GIST patients that are unlikely to respond to currently approved treatments. In addition, it can identify which patients need a higher dose [...]

18 06, 2018

GIST Updates from the ASCO Annual Meeting 2018

By |2018-10-29T13:43:20-04:00June 18th, 2018|Clinical Trials, News, Research|

Executive Director, Norman Scherzer, and Real World Evidence Data Scientist, Dr. Yu Wang, of the Life Raft Group recently attended the ASCO (American Society of Clinical Oncologists) 2018 meeting in Chicago. Dr. Wang describes [...]

9 01, 2018

Deciphera Pharmaceuticals Announces the Start of Phase 3 Clinical Trial with DCC-2618 in GIST

By |2018-10-29T13:46:27-04:00January 9th, 2018|Clinical Trials, News|

On January 4th, 2018 Deciphera Pharmaceuticals, Inc, announced the start of the Phase 3 INVICTUS trial. This randomized trial is for 4th line GIST patients that have failed (or are intolerant) the [...]

24 05, 2016

Update on Blueprint Medicines Clinical Trial for BLU-285

By |2019-07-03T10:45:21-04:00May 24th, 2016|Clinical Trials, News, Research|

Recently a number of companies have begun to develop therapeutic options that target some of the rarer mutations in GIST. As there are currently no approved treatments specifically for these patients, this [...]

16 06, 2015

Being Your Own Warrior: Karen Darnell’s Personal Battle

By |2018-11-06T12:58:26-04:00June 16th, 2015|Member Stories, News|

Karen Darnell appreciates the value of life jackets. In her GIST journey, she recognizes the importance of having one constructed from the fabric of family support, GIST experts, email communities and the Life Raft [...]

Need a new search?

If you didn't find what you were looking for, try a new search!